A Pitfall of the Androgen Deprivation Therapy for Salivary Duct Carcinoma: Hormonal Therapy-Induced Castrate-Resistant Prostate Cancer.
Shugo YajimaYasukazu NakanishiShunya MatsumotoKenji TanabeHitoshi MasudaPublished in: Journal of maxillofacial and oral surgery (2022)
We reported a case of castrate-resistant prostate cancer diagnosed during the ADT for metastatic SDC. The present case emphasizes the importance of screening for prostate cancer at the initiation of ADT treatment and during treatment.